JAZZ Financials
Jazz Pharmaceuticals PLC - Financial statements & key metrics
Stock Price
$252.33
Market Cap
$14.97B
P/E Ratio
1988.1
EPS
$-6.15
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$4.07B
Gross Profit
-
Operating Income
-
Net Income
$560.12M
EPS (Diluted)
$8.65
Balance Sheet Highlights
Total Assets
$12.01B
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$2.41B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$1.40B
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
22.3%
Net Margin
-8.9%
ROE
-9.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is JAZZ revenue?
JAZZ's most recent quarterly revenue was $4.07B. Annual revenue can be calculated by summing the four most recent quarters.
Is JAZZ profitable?
JAZZ reported a profit of $560.12M in the most recent quarter. The net profit margin is -8.9%.
What is JAZZ market cap?
JAZZ has a market capitalization of $14.97B, making it a large-cap stock.
Does JAZZ have debt?
View JAZZ's balance sheet for debt information.
What is JAZZ cash flow?
Cash flow data is available in the full financial statements.